Human papillomavirus vaccination uptake in the Rio Grande Valley of Texas: Results from a pilot community‐based educational and school‐based vaccination program

Author:

Rodriguez Ana M.1ORCID,Do Thuy Quynh N.2ORCID,Chen Lu3ORCID,Schmeler Kathleen M.4,Montealegre Jane R.5,Kuo Yong‐Fang3

Affiliation:

1. Department of Obstetrics and Gynecology University of Texas Medical Branch Galveston Texas USA

2. Department of Preventive Medicine and Population Health University of Texas Medical Branch Galveston Texas USA

3. Office of Biostatistics, Department of Preventive Medicine and Population Health University of Texas Medical Branch Galveston Texas USA

4. Department of Gynecologic Oncology and Reproductive Medicine The University of Texas MD Anderson Cancer Center Houston Texas USA

5. Department of Pediatrics, Section of Hematology‐Oncology, Dan L Duncan Comprehensive Cancer Center, Deputy Director, Office of Outreach and Health Disparities Baylor College of Medicine Houston Texas USA

Abstract

AbstractObjectiveTo pilot and evaluate a combined community‐based education and middle school‐based human papillomavirus (HPV) vaccination program in a rural, medically underserved Texas area.MethodsThe study included 2276 students enrolled at three Rio Grande City Grulla Independent School District, (RGCGISD, formerly Rio Grande City Consolidated Independent School District) middle schools (08/2016–02/2020). The intervention took place in a middle school setting with the community‐based, physician‐led HPV education campaign starting in 08/2016, and a school‐based vaccination program (Phase 1: 08/2017; Phase 2: 08/2018). Pre‐ and postintervention HPV vaccination rates were tracked against 2016 National Immunization Survey‐Teen rates (target: initiation 49.3%; completion 32.9%). Summary statistics were stratified by middle school.ResultsIn 2016, HPV vaccine initiation and completion rates for RGCGISD were lower than the national average (39.7% and 17.9%, respectively). In 2020, the overall HPV vaccine initiation rate increased by 58.0% (from 39.7% to 68.5%) and completion rates doubled (from 17.9% to 42.1%). The median age at HPV vaccine initiation and HPV vaccine completion (range) were 11.2 years (9–15) and 12 years (9–15). The median interval between HPV vaccine doses (range) was 287 days (36–1576). There were different between males and females among the three middle schools.ConclusionsMiddle schools serve as a feasible, effective interventional setting for delivering and increasing HPV education and vaccine uptake among adolescents, which offers substantial long‐term health benefits.

Funder

National Institutes of Health

Cancer Prevention and Research Institute of Texas

Publisher

Wiley

Reference40 articles.

1. An Opportunity for Cancer Prevention During Preadolescence and Adolescence: Stopping Human Papillomavirus (HPV)-Related Cancer Through HPV Vaccination

2. Centers for Disease Control and Prevention.HPV‐Associated Cancers Statistics.2015. Accessed September 1 2021.http://www.cdc.gov/cancer/hpv/statistics/index.htm

3. Use of 9‐valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices;Petrosky E;MMWR Morb Mortal Wkly Rep,2015

4. Promising alternative settings for HPV vaccination of US adolescents

5. Promising alternative settings for HPV vaccination of US adolescents

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3